Specific modulation of H3K9 methylation by KDM4B could block ICAM1 gene expression induced by several vascular factors such as inflammation, high blood glucose levels, and hypoperfusion, which are well-known risk factors for AD. Here, KDM4B is linked to Alzheimer disease.